Mepro Pharmaceuticals Private Limited, a active private limited company, was established on 31 August 1982 in Surendra Nagar, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1982PTC005451. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.40 Cr and a paid-up capital of ₹5.35 Cr.
It upholds a compliant status. Employing 543 professional, Its leadership includes Prakash Navinchandra Shah (Director), Bharatkumar Chabildas Shah (Director), Suresh Chhabildas Shah (Director). Past directors included Prakash Navinchandra Shah, Bharatkumar Chabildas Shah, Suresh Chhabildas Shah. It holds ₹169.20 Cr open charges and ₹12.50 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1003 - Gidc Wadhwan, Surendra Nagar, Gujarat, 363035.
U24231GJ1982PTC005451
005451
31 August 1982
₹5.40 Cr
₹5.35 Cr
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Mepro Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prakash Navinchandra Shah | Director | 17 Jul 2004 | Current |
| Bharatkumar Chabildas Shah | Director | 31 Aug 1982 | Current |
| Suresh Chhabildas Shah | Director | 31 Aug 1982 | Current |
| Vijay Chhabildas Shah | Whole-Time Director | 31 Aug 1982 | Current |
| Rajesh Sumanlal Shah | Director | 30 Sep 1987 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Whole-Time Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Whole-Time Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 13 Oct 2012 | Past |
| Pramod Abcsdd | Director | 23 Dec 2015 | Past |
| Pramod Abcsdd | Director | 13 Oct 2012 | Past |
| Pramod Abcsdd | Company Secretary | 31 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mepro Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 20.64% increase. The company also saw a substantial improvement in profitability, with a 142.48% increase in profit. The company's net worth Soared by an impressive increase of 26.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Mepro Pharmaceuticals had a promoter holding of 23.02% and a public holding of 76.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,692,000,000.00
₹124,990,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2022 | Others | ₹5.00 Cr | Open |
| 17 Oct 2019 | Yes Bank Limited | ₹10.00 Cr | Open |
| 17 Oct 2019 | Others | ₹38.50 Cr | Open |
| 21 May 2019 | Yes Bank Limited | ₹10.00 Cr | Open |
| 21 May 2019 | Yes Bank Limited | ₹38.50 Cr | Open |
Explore comprehensive loan charge details -
Mepro Pharmaceuticals has a workforce of 543 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Mepro Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mepro Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mepro Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Mepro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100668963 was registered on 05 Dec 2022. was completed.
Progress on A charge with Yes Bank Limited of Rs. 10.00 Cr registered on 17 Oct 2019 with Charge ID 100300344 was modified on 21 Jul 2022. was documented.
Progress on A charge with Yes Bank Limited of Rs. 10.00 Cr registered on 21 May 2019 with Charge ID 100268524 was modified on 23 Mar 2022. was documented.
A charge with Yes Bank Limited of Rs. 38.50 Cr registered on 21 May 2019 with Charge ID 100268529 was modified on 23 Mar 2022. was recorded as a recent event.
The CIN of Mepro Pharmaceuticals Private Limited is U24231GJ1982PTC005451.
Mepro Pharmaceuticals Private Limited is headquartered at 1003 - Gidc Wadhwan, Surendra Nagar, Gujarat, 363035.
Mepro Pharmaceuticals Private Limited was incorporated on 31 August 1982.
The current directors of Mepro Pharmaceuticals Private Limited are
The primary industry of Mepro Pharmaceuticals Private Limited is Manufacturing.
Mepro Pharmaceuticals Private Limited is unlisted.
The authorized capital of Mepro Pharmaceuticals Private Limited is ₹5.40 Cr, and the paid-up capital is ₹5.35 Cr.
The compliance status of Mepro Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX